Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.
5 papers
Anxiety disorders are a group of conditions marked by persistent, excessive fear or worry and behaviors (like avoidance) that cause real trouble in daily life. They are the most common class of psychiatric disorder — large surveys report that up to 33.7% of people will have one in their lifetime…
This large review combined 441 randomized trials with 33,881 patients to measure how many people show a clear response to psychotherapy across eight mental disorders. Response was defined as at least a 50% reduction in symptoms from before to after treatment. Pooled response rates were modest (for example, about 42%…
Researchers reviewed published clinical trials testing psychedelic drugs for people diagnosed with anxiety disorders. They found nine trials that used ayahuasca, ketamine, LSD, MDMA, or psilocybin. Overall, the studies showed reduced anxiety symptoms and better self-image or social functioning for people with generalized anxiety, social anxiety, or anxiety linked to…
This paper describes a 23-year-old woman whose recurring dizziness was linked to panic attacks and agoraphobia and who got better after medicine and therapy. The authors review studies showing that many people who complain of dizziness have anxiety or panic disorders, that routine ear and balance tests can be normal,…
This meta-analysis combined 85 studies with 764,403 adults to estimate how common anxiety and depression are in people with vestibular disorders. It found higher rates of anxiety (31.4% vs. 8.3%) and depression (28.3% vs. 4.7%) in people with vestibular problems than in controls. The pooled relative risks were higher for…
